These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1404215)

  • 21. [Abnormal lipoprotein metabolism in CKD].
    Hirano T
    Nihon Jinzo Gakkai Shi; 2013; 55(7):1276-9. PubMed ID: 24288963
    [No Abstract]   [Full Text] [Related]  

  • 22. Diagnosis and management of lipid disorders in children.
    Rocchini AP
    Heart Dis Stroke; 1994; 3(5):247-54. PubMed ID: 7820340
    [No Abstract]   [Full Text] [Related]  

  • 23. Recent trials of lipid lowering.
    Ray KK; Cannon CP; Braunwald E
    Int J Clin Pract; 2007 Jul; 61(7):1145-59. PubMed ID: 17577297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular mechanism of fatty acids impact on plasma lipid profile (part I)].
    Swierczyński J; Wołyniec W; Chmielewski M; Rutkowski B
    Przegl Lek; 2007; 64(1):37-41. PubMed ID: 18183830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APOE gene polymorphisms and response to statin therapy.
    Zintzaras E; Kitsios GD; Triposkiadis F; Lau J; Raman G
    Pharmacogenomics J; 2009 Aug; 9(4):248-57. PubMed ID: 19529002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Biochemical factors of coronary atherosclerosis risk].
    Titov VN
    Klin Lab Diagn; 1993; (4):30-7. PubMed ID: 8000789
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholesterol efflux capacity, carotid atherosclerosis, and cerebrovascular symptomatology.
    Doonan RJ; Hafiane A; Lai C; Veinot JP; Genest J; Daskalopoulou SS
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):921-6. PubMed ID: 24558111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid metabolism parameters in patients with multi-infarct dementia and Alzheimer's type dementia].
    Sygitowicz G; Minor A; Pachecka J; Jura E; Ryglewicz D; Członkowska A
    Neurol Neurochir Pol; 1996; 30(2):213-9; quiz 220. PubMed ID: 8756248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipid modification in type 2 diabetes: the role of LDL and HDL.
    Vergès B
    Fundam Clin Pharmacol; 2009 Dec; 23(6):681-5. PubMed ID: 19650852
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of optimal lipid value achievement between 2005 and 2009 in patients with mixed dyslipidaemia on cardiovascular event rates.
    Cziraky MJ; Tan H; Bullano MF; Yu J; Schiebinger R; Willey VJ
    Int J Clin Pract; 2011 Apr; 65(4):425-35. PubMed ID: 21401832
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-adherence to lipid-lowering therapies: a need for more studies to evaluate reasons for medication non-adherence.
    Wong MC; Wang HH; Liu KS
    Int J Clin Pract; 2011 Dec; 65(12):1321-2. PubMed ID: 22093540
    [No Abstract]   [Full Text] [Related]  

  • 32. Moderate consumption of beer reduces liver triglycerides and aortic cholesterol deposit in LDLr-/- apoB100/100 mice.
    Degrace P; Moindrot B; Mohamed I; Gresti J; Clouet P
    Atherosclerosis; 2006 Dec; 189(2):328-35. PubMed ID: 16487531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipid metabolism: lipoproteins in the metabolic syndrome and subclass sex and age differences.
    van Heyningen C
    Curr Opin Lipidol; 2005 Feb; 16(1):119-20. PubMed ID: 15650571
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiovascular disease and dyslipidemia: beyond LDL.
    Pöss J; Custodis F; Werner C; Weingärtner O; Böhm M; Laufs U
    Curr Pharm Des; 2011; 17(9):861-70. PubMed ID: 21418031
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HDL management: recent advances and perspectives beyond LDL reduction.
    Ineu ML; Manenti E; da Costa JL; Moriguchi E
    Arq Bras Cardiol; 2006 Dec; 87(6):788-94. PubMed ID: 17262119
    [No Abstract]   [Full Text] [Related]  

  • 36. Intervening on HDL-C: is it possible? Does it work?
    Wierzbicki AS
    Int J Clin Pract; 2007 Nov; 61(11):1782-6. PubMed ID: 17935541
    [No Abstract]   [Full Text] [Related]  

  • 37. The role of high-density lipoprotein cholesterol in risk for posttraumatic stress disorder: taking a nutritional approach toward universal prevention.
    Hamazaki K; Nishi D; Yonemoto N; Noguchi H; Kim Y; Matsuoka Y
    Eur Psychiatry; 2014 Sep; 29(7):408-13. PubMed ID: 24969103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low serum HDL-cholesterol is associated with raised tumor necrosis factor-alpha during ENL reactions.
    Memon RA; Kifayet A; Shahid F; Lateef A; Chiang J; Hussain R
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):1-11. PubMed ID: 9207748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Visceral leishmaniasis is associated with marked changes in serum lipid profile.
    Liberopoulos EN; Apostolou F; Gazi IF; Kostara C; Bairaktari ET; Tselepis AD; Elisaf M
    Eur J Clin Invest; 2014 Aug; 44(8):719-27. PubMed ID: 24920396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.
    Grion CM; Cardoso LT; Perazolo TF; Garcia AS; Barbosa DS; Morimoto HK; Matsuo T; Carrilho AJ
    Eur J Clin Invest; 2010 Apr; 40(4):330-8. PubMed ID: 20486994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.